Avalyn Pharma Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2024 | — | — | $24.0M |
| Mar 2025 | — | — | $28.8M |
| Jun 2025 | — | — | $61.3M |
| Dec 2025 | $15.3M | $148.9M | $52.3M |
| Mar 2026 | $27.7M | $135.7M | $92.3M |
| Jun 2026 | $27.1M | $425.4M | $264.2M |
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2024 | — | — | $24.0M |
| Mar 2025 | — | — | $28.8M |
| Jun 2025 | — | — | $61.3M |
| Dec 2025 | $15.3M | $148.9M | $52.3M |
| Mar 2026 | $27.7M | $135.7M | $92.3M |
| Jun 2026 | $27.1M | $425.4M | $264.2M |